Associate Ii

Associate II - Finance

**Category**:Finance

**Location**:Bangalore, Karnataka, IN

**Department: Finance GBS - Intercompany COE**

**About the department**
- Global Finance GBS Bangalore was established in 2007, is currently responsible for supporting Accounting, Finance & Procurement, Financial Planning & Analysis (FP&A) for Headquarters, region Europe, North America, International Operations (IO) & GBS Bangalore. The main purpose of our existence is to provide superior service to our stakeholders consistently and add value to the processes in terms of standardization and efficiency.

**The Position**
- As an Associate II in Finance GBS - Intercompany CoE, you will be participating in the daily tasks within the department and participate in the regular period end activities. Focus areas would be the regular tasks of banking operations including period end activities. Along with this, you will be responsible for below mentioned activities:

- Responsible for the intercompany accounting tasks, accounting of intercompany invoices, cross company posting along with supporting affiliates and customer queries.
- Involved in managing intercompany reconciliations and month-end reporting.
- Experience working with SAP and accounts receivables or accounts payable tasks including intercompany transactions and reconciliations.
- Transaction processing of service fee invoices and ensure correct documentation compared to contract.
- Ensure correct VAT handling of transactions with affiliates along with coordination with the GL team during month end closure.

**Qualifications**
- Minimum of Bachelor of Commerce or equivalent qualification with good academic track record and grades.
- Minimum 1 to 3 years of experience in R2R(Intercompany process).
- Ability to learn new things.
- Ability to work with limited supervision.
- Team player.
- Problem solving and analytical skills.
- Strong communication skills.
- Strong work ethic and sense of responsibility.

**Working at Novo Nordisk**
- Novo Nordisk is a leading global healthcare company with a 100-year legacy of driving change to defeat serious chronic diseases. Building on our strong legacy within diabetes, we are growing massively and expanding our commitment, reaching millions around the world and impacting more than 40 million patient lives daily. All of this has made us one of the 20 most valuable companies in the world by market cap. Our success relies on the joint potential and collaboration of our more than 63,000 employees around the world. We recognize the importance of the unique skills and perspectives our people bring to the table, and we work continuously to bring out the best in them. Working at Novo Nordisk, we’re working toward something bigger than ourselves, and it’s a collective effort. Join us

**Contact**

**Deadline**
21st January 2025.

**_Disclaimer_**
- It has been brought to our attention that there have recently been instances of fraudulent job offers, purporting to be from Novo Nordisk and/or its affiliate companies. The individuals or organizations sending these false employment offers may pose as a Novo Nordisk recruiter or representative and request personal information, purchasing of equipment or funds to further the recruitment process or offer paid trainings. Be advised that Novo Nordisk does not extend unsolicited employment offers. Furthermore, Novo Nordisk does not charge prospective employees with fees or make requests for funding as a part of the recruitment process._
- We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
- At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.